Clinical-trial consent & regulatory docs

Clinical trials run on informed consent, IRB submissions, and site agreements — signature-gated, audit-critical, and version-controlled across many sites.

Vitals (seed — unverified): market: large clinical-trial spend · multi-site · buyer: sponsors / CROs / sites · model: enterprise · whitespace: ★★☆

Research status: queued

Seed thesis only — not yet researched to evidence standard. Every claim below is a SPECULATIVE starting hypothesis to be verified, sharpened, or killed during the deep dive.

Seed thesis

• The mess: Consent version control across sites; IRB submission assembly; site-agreement execution; proving who signed which version when.
• Why now: Accessible-doc + signing + audit strengths fit; agents can manage versioning and assembly. Regulated and slow.
• The money: High-value trials; compliance is non-negotiable.
• Whitespace: Perfect audit/sign fit; regulated, gated, slow sales.